WST
WEST PHARMACEUTICAL SERVICES INC
$328.82
-0.46%
$23.2B
No data for this timeframe.
Vol
Market Cap$23.2B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (82%)
Inst. Holders50 funds
Inst. Value$10.7B
Inst. Activity28 buys / 22 sells
Insider Activity0B / 2S
Insider Net $-$1.1M
SEC Reports9
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. PA·CIK 0000105770·Prev Close $330.34
Recent Activity
May 11, 2026
SEC
West Pharmaceutical (WST) disclosed a material cybersecurity attack on May 7, 2026, with data exfiltration and system en
8-K — Impact 7/10
May 6, 2026
SEC
Two officers sold a total of $1.13M in stock post-strong Q1 earnings; nine directors received non-cash stock grants. Sal
CLUSTER — Impact 2/10
May 6, 2026
SEC
Insider cluster at West Pharmaceutical Services shows $1.13M in open-market sales by two non-C-suite executives shortly
CLUSTER — Impact 2/10
May 4, 2026
Insider
BUTHMAN MARK A was granted 791 shares
Director
May 4, 2026
Insider
Feehery William F was granted 791 shares
Director
May 4, 2026
Insider
FRIEL ROBERT F was granted 791 shares
Director
Inst.
GENERATION INVESTMENT MANAGEMENT LLP — ADD
2,243,976 shares ($562.4M)
Inst.
FMR LLC — DOUBLED
1,249,748 shares ($313.2M)
Price Targets
$358.79
+9.1% upside
Buy
Current $328.82
Low $310.00
Median $356.50
High $400.00
14 analysts
$310.00
$400.00
Analyst Ratings
7Strong Buy
11Buy
4Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 9, 2026 | Barclays | UPGRADE | Equal-Weight → Overweight |
| Jun 2, 2026 | Stephens & Co. | REITERATE | Overweight → Overweight |
| May 29, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight → Equal-Weight |
| Apr 27, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Apr 14, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $2.08 | $2.05 — $2.10 | 13% YoY | 11 |
| Next Q | $2.12 | $2.08 — $2.17 | 8% YoY | 11 |
| Current FY | $8.61 | $8.47 — $8.82 | 18% YoY | 15 |
| Next FY | $9.56 | $9.07 — $10.28 | 11% YoY | 15 |
Latest Reports
BEARISH
8-K
7/10
West Pharmaceutical (WST) disclosed a material cybersecurity attack on May 7, 2026, with data exfiltration and system en
May 11, 2026
NEUTRAL
CLUSTER
2/10
Two officers sold a total of $1.13M in stock post-strong Q1 earnings; nine directors received non-cash stock grants. Sal
May 6, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $1.7B | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.2B | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.0B | — |
| STATE STREET CORP | $825.6M | — |
| Artisan Partners Limited Partnership | $666.2M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 4, 2026 | BUTHMAN MARK | A | $0.00 |
| May 4, 2026 | Feehery William | A | $0.00 |
| May 4, 2026 | FRIEL ROBERT | A | $0.00 |
| May 4, 2026 | HAUGEN JANET | A | $0.00 |
| May 4, 2026 | Joseph Molly | A | $0.00 |
50 institutional holders with $10.7B total value (42,998,429 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 28 institutions added/increased vs 22 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6,836,714 | $1.7B | 16.0% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 4,683,286 | $1.2B | 10.9% | — |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4,094,009 | $1.0B | 9.6% | — |
| 4 | STATE STREET CORP | 3,293,778 | $825.6M | 7.7% | — |
| 5 | Artisan Partners Limited Partnership | 2,657,893 | $666.2M | 6.2% | — |
| 6 | GENERATION INVESTMENT MANAGEMENT LLP | 2,243,976 | $562.4M | 5.2% | ADD +43.7% |
| 7 | MORGAN STANLEY | 1,458,282 | $365.5M | 3.4% | — |
| 8 | FMR LLC | 1,249,748 | $313.2M | 2.9% | DOUBLED +1039.7% |
| 9 | APG Asset Management N.V. | 1,267,282 | $275.7M | 2.6% | — |
| 10 | Invesco Ltd. | 1,056,007 | $264.7M | 2.5% | — |
| 11 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 858,298 | $215.1M | 2.0% | — |
| 12 | TD ASSET MANAGEMENT INC | 768,953 | $192.7M | 1.8% | ADD +26.9% |
| 13 | GOLDMAN SACHS GROUP INC | 727,617 | $182.4M | 1.7% | — |
| 14 | Amundi | 644,065 | $161.4M | 1.5% | ADD +85.4% |
| 15 | Capital Research Global Investors | 604,011 | $151.4M | 1.4% | NEW |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 554,332 | $138.9M | 1.3% | — |
| 17 | Epoch Investment Partners, Inc. | 545,050 | $136.6M | 1.3% | — |
| 18 | SEI INVESTMENTS CO | 529,261 | $132.7M | 1.2% | — |
| 19 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 510,516 | $128.0M | 1.2% | ADD +69.9% |
| 20 | Legal & General Group Plc | 506,458 | $126.9M | 1.2% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | ADD | 1,561,869 | 2,243,976 | +43.7% | $562.4M | 2026-Q1 |
| FMR LLC | DOUBLED | 109,654 | 1,249,748 | +1039.7% | $313.2M | 2026-Q1 |
| TD ASSET MANAGEMENT INC | ADD | 605,726 | 768,953 | +26.9% | $192.7M | 2026-Q1 |
| Amundi | ADD | 347,426 | 644,065 | +85.4% | $161.4M | 2026-Q1 |
| Capital Research Global Investors | NEW | — | 604,011 | — | $151.4M | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 300,404 | 510,516 | +69.9% | $128.0M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | TRIM | 531,846 | 381,813 | -28.2% | $95.7M | 2026-Q1 |
| WELLINGTON MANAGEMENT GROUP LLP | DOUBLED | 15,860 | 248,636 | +1467.7% | $62.3M | 2026-Q1 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | ADD | 123,336 | 232,917 | +88.8% | $58.4M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 104,736 | 209,660 | +100.2% | $52.5M | 2026-Q1 |
| Holocene Advisors, LP | ADD | 127,717 | 203,621 | +59.4% | $51.0M | 2026-Q1 |
| Neuberger Berman Group LLC | TRIM | 427,512 | 181,853 | -57.5% | $45.6M | 2026-Q1 |
| Allianz Asset Management GmbH | DOUBLED | 24,250 | 176,560 | +628.1% | $44.3M | 2026-Q1 |
| Point72 Asset Management, L.P. | TRIM | 235,037 | 159,350 | -32.2% | $39.9M | 2026-Q1 |
| Assenagon Asset Management S.A. | TRIM | 251,006 | 137,561 | -45.2% | $34.5M | 2026-Q1 |
| PRUDENTIAL FINANCIAL INC | TRIM | 163,091 | 96,412 | -40.9% | $24.2M | 2026-Q1 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | DOUBLED | 38,157 | 76,525 | +100.6% | $19.2M | 2026-Q1 |
| Asset Management One Co., Ltd. | TRIM | 125,004 | 74,797 | -40.2% | $18.7M | 2026-Q1 |
| CREDIT AGRICOLE S A | TRIM | 88,989 | 66,626 | -25.1% | $16.7M | 2026-Q1 |
| Korea Investment CORP | TRIM | 110,970 | 66,003 | -40.5% | $16.5M | 2026-Q1 |
| TUDOR INVESTMENT CORP ET AL | ADD | 40,670 | 65,415 | +60.8% | $16.4M | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 9,412 | 65,346 | +594.3% | $16.4M | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | ADD | 42,911 | 60,705 | +41.5% | $15.2M | 2026-Q1 |
| Baird Financial Group, Inc. | TRIM | 146,206 | 57,287 | -60.8% | $14.4M | 2026-Q1 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | DOUBLED | 2,844 | 50,520 | +1676.4% | $12.7M | 2026-Q1 |
18 unique insiders with 37 transactions. Net insider value: -$1.1M ($0.00 bought, $1.1M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 4, 2026 | BUTHMAN MARK A | Director | AWARD | 791 | — | — |
| May 4, 2026 | Feehery William F | Director | AWARD | 791 | — | — |
| May 4, 2026 | FRIEL ROBERT F | Director | AWARD | 791 | — | — |
| May 4, 2026 | HAUGEN JANET BRUTSCHEA | Director | AWARD | 791 | — | — |
| May 4, 2026 | Joseph Molly | Director | AWARD | 791 | — | — |
| May 4, 2026 | Keller Deborah L | Director | AWARD | 791 | — | — |
| May 4, 2026 | Pucci Paolo | Director | AWARD | 791 | — | — |
| May 4, 2026 | LAI GOLDMAN MYLA | Director | AWARD | 791 | — | — |
| May 4, 2026 | Lockhart Stephen H | Director | AWARD | 791 | — | — |
| May 4, 2026 | Michels Douglas A | Director | AWARD | 791 | — | — |
| Apr 27, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | EXERCISE | 2,817 | $83.47 | $235.1K |
| Apr 27, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | SELL | 2,817 | $305.20 | $859.8K |
| Apr 27, 2026 | Winters Chad | VP, Chief Accounting Officer | EXERCISE | 896 | $173.22 | $155.2K |
| Apr 27, 2026 | Winters Chad | VP, Chief Accounting Officer | SELL | 896 | $300.67 | $269.4K |
| Mar 31, 2026 | HAUGEN JANET BRUTSCHEA | Director | AWARD | 52 | $250.64 | $13.0K |
| Mar 1, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | AWARD | 1,131 | — | — |
| Mar 1, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | AWARD | 2,691 | — | — |
| Mar 1, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | AWARD | 3,082 | — | — |
| Mar 1, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | AWARD | 7,337 | — | — |
| Mar 1, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | AWARD | 437 | — | — |
| Mar 1, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | AWARD | 1,040 | — | — |
| Mar 1, 2026 | Winters Chad | VP, Chief Accounting Officer | AWARD | 340 | — | — |
| Mar 1, 2026 | Winters Chad | VP, Chief Accounting Officer | AWARD | 808 | — | — |
| Mar 1, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | AWARD | 1,712 | — | — |
| Mar 1, 2026 | Finch Norman D. Jr. | SVP, GC & Corporate Secretary | AWARD | 1,285 | — | — |
| Mar 1, 2026 | Finch Norman D. Jr. | SVP, GC & Corporate Secretary | AWARD | 3,057 | — | — |
| Mar 1, 2026 | Green Eric Mark | President, CEO and Board Chair | AWARD | 6,986 | — | — |
| Mar 1, 2026 | Green Eric Mark | President, CEO and Board Chair | AWARD | 16,630 | — | — |
| Mar 1, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | AWARD | 720 | — | — |
| Feb 20, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | EXERCISE | 383.382 | — | — |
| Feb 20, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | TAX W/H | 129.545 | $241.12 | $31.2K |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | EXERCISE | 60.22 | — | — |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | TAX W/H | 22.069 | $241.12 | $5.3K |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | EXERCISE | 89.328 | — | — |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | TAX W/H | 30.184 | $241.12 | $7.3K |
| Feb 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | TAX W/H | 1,250.034 | $246.16 | $307.7K |
| Feb 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | EXERCISE | 4,230.525 | — | — |
9 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 7 neutral. Avg impact: 3.2/10.
BEARISH
8-K
7/10
West Pharmaceutical (WST) disclosed a material cybersecurity attack on May 7, 2026, with data exfilt
May 11, 2026
NEUTRAL
CLUSTER
2/10
Two officers sold a total of $1.13M in stock post-strong Q1 earnings; nine directors received non-ca
May 6, 2026
NEUTRAL
CLUSTER
2/10
Insider cluster at West Pharmaceutical Services shows $1.13M in open-market sales by two non-C-suite
May 6, 2026
NEUTRAL
CLUSTER
2/10
Two insiders at West Pharmaceutical Services sold a total of $1.13M in shares, representing a trivia
May 6, 2026
NEUTRAL
CLUSTER
2/10
Insider cluster at West Pharmaceutical Services includes two small open-market sales ($1.13M total)
May 6, 2026
NEUTRAL
CLUSTER
2/10
Two insiders sold $1.13M worth of WST shares (0.005% of market cap) following strong Q1 earnings. Th
May 6, 2026
NEUTRAL
CLUSTER
2/10
Two WST insiders (Sr. VP HR and VP/CAO) sold a combined $1.13M in open-market shares on April 27, 20
Apr 29, 2026
BULLISH
8-K
8/10
West Pharmaceutical Services reported strong Q1 2026 results with revenue of $844.9M (+21.0% YoY) an
Apr 23, 2026
NEUTRAL
DEFA14A
2/10
Analysis based on filing metadata only — document content was unavailable
Mar 12, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (82% buy). Based on 22 analysts: 7 strong buy, 11 buy, 4 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$358.79 mean target
+9.1% upside
Buy (1.33)
$310.00 Low
$400.00 High
| Metric | Value |
|---|---|
| Current Price | $328.82 |
| Target Low | $310.00 |
| Target Mean | $358.79 |
| Target Median | $356.50 |
| Target High | $400.00 |
| # Analysts | 14 |
| Recommendation | Buy (1.33) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$2.08 | $2.05 | $2.10 | 13.1% | -0.2% | 0↑ 1↓ | $0.8B | 9.4% | 11 |
| Next Q 2026-09-30 |
$2.12 | $2.08 | $2.17 | 8.3% | -0.4% | 0↑ 1↓ | $0.8B | 1.3% | 11 |
| Current FY 2026-12-31 |
$8.61 | $8.47 | $8.82 | 18.1% | -0.1% | 0↑ 1↓ | $3.3B | 8.4% | 15 |
| Next FY 2027-12-31 |
$9.56 | $9.07 | $10.28 | 11.0% | +0.0% | 0↑ 1↓ | $3.5B | 6.2% | 15 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $2.080 | |
| 7d ago | $2.082 | -0.002 |
| 30d ago | $2.084 | -0.003 |
| 60d ago | $1.994 | +0.086 |
| 90d ago | $1.992 | +0.088 |
4 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 9, 2026 | Barclays | UPGRADE | Equal-Weight | Overweight |
| Jun 2, 2026 | Stephens & Co. | REITERATE | Overweight | Overweight |
| May 29, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 27, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 14, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 13, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 3, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 7 | 11 | 4 | 0 | 0 | 82% | |
| May 1, 2026 | 6 | 13 | 4 | 0 | 0 | 83% | |
| Apr 1, 2026 | 6 | 12 | 5 | 0 | 0 | 78% | |
| Mar 1, 2026 | 6 | 12 | 5 | 0 | 0 | 78% | |
| Feb 1, 2026 | 6 | 12 | 5 | 0 | 0 | 78% | |
| Jan 1, 2026 | 6 | 11 | 5 | 0 | 0 | 77% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 18, 2026
dark_pool
Dark Pool: WST — 0.9M shares, 28,935 trades
Week starting 2026-05-18. Total ATS volume: 864,887 shares across 28,935 trades.
May 11, 2026
dark_pool
Dark Pool: WST — 1.2M shares, 37,210 trades
Week starting 2026-05-11. Total ATS volume: 1,201,933 shares across 37,210 trades.
May 7, 2026
short_volume
Short Volume: WST — 65.5% short (0.4M / 0.5M)
Short: 353,144 | Exempt: 79 | TRF Vol: 538,798 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)
May 4, 2026
dark_pool
Dark Pool: WST — 1.3M shares, 36,869 trades
Week starting 2026-05-04. Total ATS volume: 1,270,768 shares across 36,869 trades.
Apr 27, 2026
dark_pool
Dark Pool: WST — 1.5M shares, 48,037 trades
Week starting 2026-04-27. Total ATS volume: 1,524,375 shares across 48,037 trades.
Apr 23, 2026
earnings_calendar
WST Q1 2026 Earnings Before Market Open — 2026-04-23
Apr 20, 2026
dark_pool
Dark Pool: WST — 2.4M shares, 64,592 trades
Week starting 2026-04-20. Total ATS volume: 2,445,953 shares across 64,592 trades.
Apr 13, 2026
dark_pool
Dark Pool: WST — 1.1M shares, 38,605 trades
Week starting 2026-04-13. Total ATS volume: 1,127,417 shares across 38,605 trades.
Apr 6, 2026
dark_pool
Dark Pool: WST — 1.0M shares, 38,267 trades
Week starting 2026-04-06. Total ATS volume: 1,029,729 shares across 38,267 trades.
Mar 30, 2026
dark_pool
Dark Pool: WST — 1.0M shares, 32,660 trades
Week starting 2026-03-30. Total ATS volume: 1,016,881 shares across 32,660 trades.
Mar 23, 2026
dark_pool
Dark Pool: WST — 1.3M shares, 39,279 trades
Week starting 2026-03-23. Total ATS volume: 1,293,992 shares across 39,279 trades.
Mar 16, 2026
dark_pool
Dark Pool: WST — 1.2M shares, 40,812 trades
Week starting 2026-03-16. Total ATS volume: 1,177,100 shares across 40,812 trades.
Mar 9, 2026
dark_pool
Dark Pool: WST — 1.3M shares, 42,792 trades
Week starting 2026-03-09. Total ATS volume: 1,327,551 shares across 42,792 trades.
Mar 2, 2026
dark_pool
Dark Pool: WST — 1.1M shares, 39,876 trades
Week starting 2026-03-02. Total ATS volume: 1,108,526 shares across 39,876 trades.
Feb 24, 2026
short_interest
FTD: WST — 7,162 shares ($1.7M) failed to deliver
Settlement: 20260224, Price: $244.22, FTD Value: $1,749,103.64, WEST PHARMACEUTICAL SERV INC